Krishana Phoschem's margin surge contradicts April caution; revenue guidance trimmed
Q1 EBITDA margin hit 16.7% versus FY26's 12.34%, reversing management's earlier warning of pressure. Revenue growth guidance cut to 30-35% from 40% without explanation.
What's new
- Q1 revenue ₹532 cr, up 35% YoY; EBITDA ₹89 cr, up 36% YoY; margin 16.7%.
- Five new NPK grades with 21% EBITDA margins replace legacy 8-9% grades.
- NPK-DAP capacity utilization at 43% due to raw material constraints, expected to normalize.
- Signed 10-year green ammonia supply agreement with SECI for FY29 at cost parity.
Themes from the call
Margins
New NPK grades drove manufacturing EBITDA margin to 21%, well above peer average of 8-9%, offsetting raw material cost inflation.
Demand
June monsoon deficit reversed to 8% by early July, accelerating Kharif sowing; industry NPK sales up 33% YoY in April-May.
Capacity
NPK-DAP utilization at 43% due to supply constraints; management confident of ₹500+ cr quarterly revenue from Q2 onward.
Guidance watch
- Revenue growth of 30-35% for FY27 (down from prior 40% guidance).
- Quarterly revenue run-rate of ₹500+ cr expected from Q2 as raw material supply normalizes.
- Green ammonia supply from FY29 at cost parity to gray ammonia.
Risk flags
- Finance costs surged to ₹50 cr (from ₹32 cr) due to new capacity, compressing PAT margin to 8.9%.
- NPK-DAP utilization at 43% depends on raw material availability; any supply disruption could delay ramp-up.
- Contradiction in margin outlook between April and July calls raises credibility questions on guidance.
Key quotes
-
"We will be the lowest-cost raw material buyer in the country for green ammonia once this facility comes in."
— Praveen Oswal, Managing Director -
"Margins will be under pressure, and the levels achieved in FY26 may not be fully sustainable."
— Management, Apr 2026 call -
"We have performed well this quarter and expect margins will be very good for the coming quarters as well."
— Management, Jul 2026 call
The brief
Krishana Phoschem's Q1 earnings were strong on the surface: revenue up 35%, EBITDA up 36%, and a margin of 16.7% that surprised the street. But the numbers sit uneasily with what management said three months ago. In April, they warned that margins would be under pressure and that FY26 levels might not be sustainable. Sulfur prices have since risen from ₹55,000-70,000 to ₹100,000 per ton. Yet margins expanded. Management's explanation (new NPK grades with 21% margins and lower-cost inventory) is plausible but partial. The grades are real: five new complex formulations produced at 53,500 tons contributed to a manufacturing EBITDA margin double that of peers. But the revenue guidance flip is harder to explain. April's call guided for over 40% growth; now it is 30-35%. No explicit acknowledgment was given. The debt burden is also growing: finance costs rose to ₹50 crores from ₹32 crores, compressing net margins despite operational improvement. The green ammonia deal with SECI for FY29 offers a long-term raw material anchor, but near-term execution depends on NPK-DAP capacity utilization climbing from 43% to stable levels. Management expects ₹500+ crores in quarterly revenue from Q2. The strategy (differentiated products, backward integration, and a long-term ammonia hedge) is sound. However, the guidance reversals make it harder to trust the forward narrative without more transparency.
Strong quarter, but two unexplained guidance reversals leave the outlook on shaky ground.